Trend of the Month Rapamycin & the rise of longevity medicine Read more
How Existing Clinic Owners Are Adding Longevity Medicine Services — and What It's Doing to Their Revenue

How Existing Clinic Owners Are Adding Longevity Medicine Services — and What It's Doing to Their Revenue

How Existing Clinic Owners Are Adding Longevity Medicine Services — and What It's Doing to Their RevenueNova S.
Published on: 11/06/2026

How existing clinic owners are adding longevity medicine services in 2026.

chiropractor longevity medicine expansionexisting practice anti aging expansionadd hormone optimization to clinicNAD clinic expansionexisting clinic add longevity medicinemed spa hormone optimizationexisting practice longevity revenue
Read more
NAD+ and Sermorelin: Why These Two Services Are the Anchor of Every Successful Longevity Practice in 2026

NAD+ and Sermorelin: Why These Two Services Are the Anchor of Every Successful Longevity Practice in 2026

NAD+ and Sermorelin: Why These Two Services Are the Anchor of Every Successful Longevity Practice in 2026Nova S.
Published on: 28/05/2026

Why NAD+ therapy and Sermorelin are the two anchor services of every successful longevity clinic.

NAD+ clinic business 2026NAD IV therapy clinic businessSermorelin longevity clinicNAD clinic revenuelongevity clinic anchor serviceslongevity clinic service stackNAD therapy recurring revenue
Read more
The Longevity Clinic Revenue Model: How the Best Operators Structure Income for Predictable, Recurring Growth

The Longevity Clinic Revenue Model: How the Best Operators Structure Income for Predictable, Recurring Growth

The Longevity Clinic Revenue Model: How the Best Operators Structure Income for Predictable, Recurring GrowthNova S.
Published on: 21/05/2026

The longevity clinic membership revenue model — unit economics, protocol pricing, and how the service ecosystem compounds recurring income in 2026.

longevity clinic revenue modellongevity clinic incomelongevity medicine business profitabilityanti aging clinic revenuelongevity clinic membership modelcash pay longevity clinic income
Read more
What Does It Cost to Open a Longevity Clinic in 2026?

What Does It Cost to Open a Longevity Clinic in 2026?

What Does It Cost to Open a Longevity Clinic in 2026?Nova S.
Published on: 07/05/2026

Complete breakdown of longevity clinic startup costs in 2026 — consulting, legal structure, medical director, supplier access, and working capital.

longevity clinic startup costshow much does it cost to open a longevity cliniclongevity clinic investmentanti aging clinic costlongevity medicine clinic budgetstarting a longevity cliniclongevity clinic working capitalhormone optimization clinic costNAD clinic startup investmentlongevity medicine practice budgetcash pay longevity clinic costs
Read more
Built by operators. Proven across hundreds of clinic launches.

A leading regenerative health clinic consulting firm. We help entrepreneurs open Regenerative Health, Longevity, and MedSpa clinics, hundreds launched and optimized, no medical background required.

Clinics Supported Nationwide
Serving Entrepreneurs Across All 50 States
No Medical Background Required
One-Time Fee. No Royalties
60 Days to Open. From Keys to First Patient*

© 2026 Altos Consulting Group. All rights reserved.

Altos Consulting Group is a business consulting and advisory firm. ACG is not a medical practice and does not provide medical care, diagnose, prescribe, dispense, or manufacture any drug, biologic, device, or therapy. At every clinic we support, all clinical and treatment decisions are made by independent, state-licensed medical providers who own and direct patient care, consistent with applicable Corporate Practice of Medicine laws. Regenerative and cash-pay therapies, including PRP, peptides, GLP-1 medications, and exosome or cellular products, are subject to federal and state regulation, and not all products or uses are FDA-approved or cleared; the FDA has stated there are currently no FDA-approved exosome products for the treatment of any disease. Clinic owners are responsible for ensuring their products, therapies, and marketing comply with all FDA, FTC, state medical board, and state advertising requirements. Any results, revenue figures, or timelines shown are illustrative, reflect specific clients under specific conditions, are not typical, and are not guarantees of income or success; individual outcomes vary by market, location, capital, regulatory conditions, and operator execution. ACG partners with vetted lending providers to help clients access capital and does not act as a lender. The "60 days to open" reference is a target, not a guarantee, and varies by state, market, and regulatory conditions. FTC Disclaimer: results described in testimonials and case studies are not typical, and individual results will vary. © 2026 Altos Consulting Group.